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Frog virus 3 (FV3) is a large DNA virus that encodes ∼100 proteins. Although the general features of FV3 replication are known, the specific
roles that most viral proteins play in the virus life cycle have not yet been elucidated. To address the question of viral gene function, antisense
morpholino oligonucleotides (asMOs) were used to transiently knock-down expression of specific viral genes and thus infer their role in virus
replication. We designed asMOs directed against the major capsid protein (MCP), an 18 kDa immediate-early protein (18K) that was thought to
be a viral regulatory protein, and the viral homologue of the largest subunit of RNA polymerase II (vPol-IIα). All three asMOs successfully
inhibited translation of the targeted protein, and two of the three asMOs resulted in marked phenotypic changes. Knock-down of the MCP
resulted in a marked reduction in viral titer without a corresponding drop in the synthesis of other late viral proteins. Transmission electron
microscopy (TEM) showed that in cells treated with the anti-MCP MO assembly sites were devoid of viral particles and contained numerous
aberrant structures. In contrast, inhibition of 18K synthesis did not block virion formation, suggesting that the 18K protein was not essential for
replication of FV3 in fathead minnow (FHM) cells. Finally, consistent with the view that late viral gene expression is catalyzed by a virus-
encoded or virus-modified Pol-II-like protein, knock-down of vPol-IIα triggered a global decline in late gene expression and virus yields without
affecting the synthesis of early viral genes. Collectively, these results demonstrate the utility of using asMOs to elucidate the function of FV3
proteins.
© 2006 Elsevier Inc. All rights reserved.Keywords: Frog virus 3; Ranavirus; Antisense morpholino oligonucleotidesIntroduction
Members of the family Iridoviridae comprise a diverse group
of large, double-stranded DNA-containing viruses that include
two genera infecting invertebrates (Iridovirus and Chlorirido-
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doi:10.1016/j.virol.2006.07.009(Ranavirus, Lymphocystivirus, and Megalocytivirus) (Chinchar
et al., 2005). FV3, the type species of the genus Ranavirus, is the
best characterized member of this family, and its study has
elucidated the basic features of iridovirus replication (Willis et
al., 1985; Chinchar, 2002; Williams et al., 2005). The complete
genomic sequences of eleven iridoviruses have been determined
including those for FV3 and four additional members of the
genus Ranavirus: tiger frog virus (TFV), Singapore grouper
iridovirus (SGIV), grouper iridovirus (GIV), and Ambystoma
tigrinum virus (ATV) (He et al., 2002; Jancovich et al., 2003; Tan
et al., 2004; Song et al., 2004; Tsai et al., 2005). Sequence
312 R. Sample et al. / Virology 358 (2007) 311–320analysis indicates that ranaviruses contain ∼100 open reading
frames (ORFs) with the potential to encode proteins of >40
amino acids. Approximately one quarter of the ORFs encode
proteins of known or presumed function, e.g., the major capsid
protein, the viral DNA polymerase, and homologs of ribonu-
cleotide reductase and the two largest subunits of RNA
polymerase II. However, more than half of the remaining
ORFs encode presumptive proteins with no other matches in the
database except to those of other iridovirus genes. Although
their function is not known, these ORFs likely encode poly-
peptides important for ranavirus replication and survival since
they are conserved in other family members.
Previous attempts to elucidate FV3 gene function through the
use of temperature-sensitive and drug-resistant mutants have
met with limited success (Chinchar and Granoff, 1984, 1986).
Earlier work identified two complementation groups (CGs)
involved with viral DNA synthesis, five CGs with roles in
assembly site formation and late gene expression, and 12 CGs
that synthesize all classes of viral protein and DNA but fail to
assemble infectious virions (Chinchar andGranoff, 1986). Study
of these and other mutants elucidated the two-stage model of
viral DNA synthesis (Goorha et al., 1981; Goorha and Dixit,
1984). However, attempts at targeting specific genes have been
unsuccessful because, unlike poxviruses and herpesviruses, it is
not yet possible to introduce mutations into iridovirus genomes
by homologous recombination. To circumvent this problem and
determine the function of specific viral genes, we describe here a
“knock-down” strategy using asMOs.
asMOs are a class of DNA-like agents composed of purines
and pyrimidines linked to 6-member morpholino rings and
joined via phosphorodiamidate bonds (Summerton and Weller,
1997; Corey and Abrams, 2001; Summerton, 2003). Because of
their unique structure, asMOs resist nuclease degradation and
are stable through several rounds of cell division (Dagle and
Weeks, 2001). They have been used extensively to knock-down
gene expression in developing embryos (Sumanas and Ekker,
2001) and have been shown to inhibit gene expression in
cultured cells (Munshi et al., 2002) and viruses (Neuman et al.,
2004; Kinney et al., 2005; Deas et al., 2005; Van den Born et al.,
2005). Moreover, nearly every asMO targeted to the region
immediately surrounding, or upstream, of the translational ini-
tiation codon, is able to block gene expression by inhibiting
translation (Ekker and Larson, 2001). In addition to blocking
viral protein synthesis, asMOs targeted to important control
regions have been shown to inhibit viral replication. Here, we
describe the use of this approach to determine the role of three
FV3 proteins in virus replication: the major capsid protein
(MCP), the 18 kDa immediate-early protein (18K), and the
largest subunit of the viral homologue of RNA polymerase II
(vPol-IIα).
Results
Inhibition of FV3 MCP synthesis
To determine the effect of targeted asMO treatment on FV3
gene expression, we initially focused on the viral MCP. TheMCP was chosen because it is the most abundant viral protein
and is readily visualized following one-dimensional electro-
phoresis on SDS-polyacrylamide gels. Lightly confluent mono-
layers of FHM cells were left untreated, or treated with Endo-
Porter (EP) alone, a control MO (CTRL) that does not bind any
known message sequence, or an anti-sense MO targeted to the
MCP mRNA (anti-MCP MO). The cultures were incubated
overnight at 26 °C, and ∼24 h later, they were infected with
FV3. One set of replicate cultures was radiolabeled from 7 to 9 h
p.i. with [35S]methionine, and viral protein synthesis monitored
by SDS-polyacrylamide gel electrophoresis (SDS-PAGE), and
viral yields were determined in a replicate set of samples at 24 h
p.i. Gel analysis of viral protein synthesis showed a marked drop
in MCP expression in the presence of the anti-MCPMO (Fig. 1,
lane 4). In contrast, a slight drop in MCP synthesis was seen
when FV3-infected cells were treated with EP alone (lane 3) or
with a control MO that does not target any known FV3 sequence
(lane 5). Phosphorimager analysis of three representative
experiments showed that treatment of FV3-infected FHM cells
with anti-MCP MO resulted in an ∼80% reduction in MCP
synthesis (Fig. 1B). In contrast, exposure to the control MO or to
EP alone resulted in only an∼20% reduction in MCP synthesis.
Determination of virus yields from three independent experi-
ments showed a 94% reduction in virus yields compared to
untreated FV3-infected cells (Fig. 2). These results clearly
indicate that asMOs targeted against the FV3 MCP transcript
markedly and specifically reduced synthesis of the cognate
protein. Moreover, this study confirmed our expectation that
inhibition of MCP synthesis adversely affected FV3 virion
formation.
To further examine the effect of inhibitingMCP synthesis, the
effects of asMO treatment were examined by transmission
electron microscopy. As shown in Fig. 3, FV3 infection induced
marked CPE in FHM cells. Consistent with virus replication,
nuclei within infected cells showed marked chromatin con-
densation and margination (compare panel A, mock-infected
cells, with panel B, FV3-infected cells). Chromatin condensa-
tion and margination were apparent in productively infected
cells (panel B) as well as in cells in which virus replication was
arrested by treatment with anti-MCP MO (panel C). Chromatin
condensation is a hallmark of apoptosis and confirms our earlier
study showing that FV3-infected cells undergo apoptosis
following productive or non-productive infection of FHM
cells (Chinchar et al., 2003). Morphologically distinct viral
assembly sites containing non-enveloped virus particles, para-
crystalline arrays of virus particles, and virions budding from the
plasma membrane were observed in productively infected cells
(Fig. 3B). Virion formation was also clearly seen in FV3-
infected cells treated with EP alone (Fig. 5A) or with a control
MO (data not shown). In contrast, FHM cells pretreated with the
anti-MCP MO prior to infection assembled few if any viral
particles (Figs. 3C and D). Although viral assembly sites were
present in cells treated with anti-MCP MO, they did not contain
characteristic icosahedral virions, but rather displayed a series of
circular, bent, and elongated structures (designated “atypical
elements,” AE) that may represent aberrant or intermediate
products of viral assembly (Figs. 3C and D). Collectively, these
313R. Sample et al. / Virology 358 (2007) 311–320results suggest that the MCP is not required for assembly site
formation, but that its presence is required for virion
morphogenesis.
Having shown that asMOs are capable of blocking the
synthesis of specific viral proteins without triggering off-tar-
geting effects such as those sometimes observed following
treatment with short, interfering RNAs (siRNA), we turned our
attention to two viral gene products whose functions have yet to
be elucidated, an abundant 18 kDa immediate-early protein
(18K), and the largest subunit of the viral homologue of host
RNA polymerase II (vPol-IIα).Inhibition of 18 K synthesis does not affect late gene expression
or viral assembly
The FV3 18 kDa immediate-early protein is a relatively
abundant protein and, by analogy to immediate-early proteins in
other virus families, was thought to play an important regulatory
role in FV3 biogenesis (Willis et al., 1984). However, in the
absence of known mutants, its precise function in FV3 repli-
cation is not known. To ascertain the role of the 18K protein in
FV3morphogenesis, we exposed FHM cells to an anti-18KMO,
and 24 h later infected them with FV3. As before, replicate
cultures were monitored by SDS-PAGE of viral proteins
radiolabeled from 7 to 9 h p.i., transmission electron microscopy,
and by determining viral yields at 24 h p.i. As shown in Fig. 4A,
treatment of cells with anti-18KMO blocked the synthesis of the
18 kDa protein (lane 5). Synthesis of the 18K protein was not
affected by treatment with EP alone (lane 4), or a control asMO
(lane 6). EP did not affect translation in mock-infected cells
(compare lanes 1 and 2). Contrary to our expectations, inhibition
of 18K synthesis had no effect on the synthesis of non-targeted
viral proteins (Fig. 4A) nor did it reduce virus yields beyond that
seen following treatment with EP alone or EP plus the control
MO (Fig. 2) suggesting that, at least in FHM cells, the 18K
protein did not play an essential role in virus replication.
Quantification of 18K yields in three independent experiments
showed that treatment with the anti-18K MO resulted in an
∼80% reduction in its synthesis (Fig. 4B). In contrast, treatment
with EP alone, a control MO, or the anti-MCP MO reduced
translation of 18K by only 20–30%. Transmission electron
micrographs (TEM) of treated cells subsequently infected with
FV3 showed that anti-18K MO affected neither assembly site
formation nor virion biogenesis (Figs. 5C and D). Inspection of
electron micrographs showed that FV3-infected cells treated
with the anti-18K MO were essentially identical to untreated, or
EP-treated, FV3-infected cells (compare Figs. 3B and 5A with
Fig. 5C). Taken together, the above results indicate that synthesis
of the 18K protein is not required for virus replication in FHM
cells and do not support the suggestion that 18K is an essential
regulatory factor.Fig. 1. Effect of anti-MCP MO on protein synthesis in FV3-infected cells. (A)
Gel analysis. Lightly confluent monolayers of FHM cells were exposed to Endo-
Porter (EP) alone or EP plus the indicated asMOs and incubated overnight.
Twenty four hours later, replicate cultures were infected with FV3 at an MOI of
20 PFU/cell and viral proteins were radiolabeled from 7–9 h p.i. with [35S]
methionine. Radiolabeled viral proteins were separated by electrophoresis on
15% SDS-polyacrylamide gels and visualized by autoradiography. The
molecular weights of marker proteins (in kDa) are shown to the left of the gel,
and the position of the MCP is indicated by an arrow. Untreated, mock-infected
FHM cells are shown in lane 1. The panel above the figure indicates whether the
cultures were infected or not, the presence of the transfection reagent, and the
identity of the MO. (B) Phosphorimager analysis. The level of MCP protein
synthesis was determined by Phosphorimager analysis following treatment of
FHM cells with EP alone, a control MO, or the anti-MCPMO. The level of MCP
synthesis in untreated, FV3-infected FHM cells is indicated in the column
marked “none.” The results of three independent experiments are shown.
Fig. 2. Viral yields following treatment with MOs. Viral yields were determined
24 h p.i. and are expressed relative to the yield in the absence of treatment, which
was set at 100%. The means of three independent experiments are shown along
with the LSD 95% confidence intervals. None, virus yield in untreated, FV3-
infected FHM cells; EP, treatment with EP alone; CTRL, treatment with EP plus
CTRL MO; 18K, treatment with anti-18K MO; MCP, treatment with anti-MCP
MO; and vPol-IIα treatment with anti-vPol-IIα MO.
Fig. 3. Transmission electron microscopy: effect of anti-MCPMO on virion formation
(C and D), and ∼24 h later infected with FV3 at an MOI ∼20 PFU/cell. At 9 h p.i., th
microscopy. (A) Untreated, mock-infected FHM cells; (B) untreated, FV3-infected ce
FV3. Panel D shows an enlargement of the atypical elements (AEs) seen within the a
large arrowheads identify virions within paracrystalline arrays; and small arrowhead
314 R. Sample et al. / Virology 358 (2007) 311–320Inhibition of late viral protein synthesis follows targeting of
vPol-IIα
Although the precise mechanisms of FV3 RNA synthesis are
not known, the current model suggests that synthesis of
immediate-early (IE) viral mRNA is catalyzed in the nucleus
by host RNA polymerase II in a reaction-dependent upon one or
more virion proteins (Chinchar, 2002; Williams et al., 2005).
Later, either within the cytoplasm of infected cells or within viral
assembly sites, a virus-modified, or a novel virus-encoded poly-
merase, transcribes late (L) viral messages. Sequencing studies
indicate that iridoviruses encode proteins with marked homol-
ogy to the two largest subunits of host RNA polymerase II and
support the view that late viral transcription is catalyzed by a
novel virus-encoded, or virus-modified, RNA polymerase
(Jancovich et al., 2003; Tan et al., 2004; Williams et al.,
2005). While plausible, formal proof of this hypothesis has
heretofore been lacking. To determine if the viral homologue of
the largest subunit of Pol II is required for late viral gene
expression, we targeted vPol-IIα production using an anti-vPol-
IIα asMO. We reasoned that, if vPol-IIα expression were. FHM cells were not treated (A and B) or exposed to EP plus the anti-MCPMO
e cells were fixed in 2% glutaraldehyde and processed for transmission electron
lls; (C and D) cells treated with anti-MCP MO, then subsequently infected with
ssembly site shown in panel C. N indicates the nucleus; *, viral assembly sites;
s identify budding virions.
Fig. 4. Effect of anti-18K MO on viral protein synthesis. (A) SDS-
polyacrylamide gel analysis. The synthesis of viral and host proteins was
monitored in mock-infected (lanes 1 and 2) and virus-infected (lanes 3–6)
cultures following no treatment (lanes 1 and 3) or exposure to EP alone (lanes
2 and 4), anti-18K MO (lane 5) or a control MO (lane 6). The positions of the
MCP and the 18K proteins are indicated. Molecular weight markers are shown
to the left of the figure. (B) Phosphorimager analysis. The level of 18K
protein synthesis following the indicated treatments was determined by
Phosphorimager analysis as described in the legend to Fig. 1. The results of
three independent experiments are shown.
315R. Sample et al. / Virology 358 (2007) 311–320inhibited, we should detect a marked inhibition of late viral
protein synthesis without a corresponding decrease in early viral
gene expression.
To determine the effect of vPol-IIα knock-down on late viral
gene expression, FHM cells were treated or not with asMOs, and24 h later infected with FV3. Cultures were radiolabeled from 7
to 9 h p.i., and viral proteins analyzed by SDS-PAGE. In these
experiments, four different MOs were used: one that was
antisense to the MCP transcript (positive control), another
positive control that targeted the 18K protein, a control MO that
does not target any known message (negative control), and one
that targeted the vPol-IIα message. As shown in Fig. 6A, late
gene expression was clearly evident in untreated FV3-infected
cells as indicated by the presence of the MCP as well as several
other characteristic late proteins (lane 2). As noted previously,
treatment with EP alone (lane 3) or with the control MO (lane 7)
had a slight inhibitory effect on both early and late viral gene
expression. As expected, treatment with asMOs targeted to the
MCP and 18K proteins blocked their synthesis, but had little to
no effect on the production of other viral proteins (lanes 4 and 6,
respectively). In contrast, treatment with an asMO targeted to
vPol-IIα (lane 5) had a marked effect on late gene expression
(indicated by the asterisks) while showing little if any inhibition
of early viral genes. Early gene expression (represented by the
bands marked E1, E2, and 18K) was as high, if not higher, than
that seen in FV3-infected cells treated with the anti-MCP MO
(compare lanes 4 and 5), whereas late gene expression was
markedly inhibited following exposure to anti-vPol-IIα MO.
Phosphorimager analysis of three independent experiments
confirmed these expectations. Synthesis of vPol-IIα was
reduced by ∼80% after treatment with anti-vPol-IIα MO (Fig.
6B). In addition, MCP expression was reduced by ∼70%
following treatment with anti-vPol-IIα (Fig. 6C), whereas 18K
expression was slightly elevated in cells treated with anti-vPol-
IIα (Fig. 6D). Consistent with the drop in late gene expression,
treatment of FV3-infected cells with an anti-vPol-IIα MO
reduced viral yields by ∼98% (Fig. 2). In support of these
studies, TEM analysis confirmed that treatment of FV3-infected
cells with the anti-vPol-IIα MO inhibited virion formation, but
not assembly site formation (Fig. 5B). Treated cells showed
large, clearly defined assembly sites that often contained an
electron dense area that likely corresponds to viral DNA.Despite
the marked reduction in MCP synthesis, assembly sites within
anti-vPol-IIα treated cells did not show the AEs seen following
treatment with an anti-MCPMO, suggesting that their formation
depends on the presence of additional late proteins besides the
MCP. Collectively, these biochemical and ultrastructural results
are consistent with the hypothesis that the largest subunit of the
viral homologue of Pol II plays a key role in late viral gene
expression.
Discussion
The aforementioned results indicate that asMOs are appro-
priate tools for transiently and specifically inhibiting (i.e.,
knocking down) expression of ranavirus genes. As with
siRNAs, they offer the potential of selectively inhibiting the
synthesis of individual viral gene products and assessing the
effect of inhibition on viral biogenesis. However, whereas
sequences targeted by siRNAs may be found anywhere within a
given message, asMOs targeted to the region preceding, or
immediately surrounding, the initiation codon readily inhibit
Fig. 5. Transmission electron microscopy: effect of anti-18K and anti-vPol-IIαMO on FV3 replication in FHM cells. Twenty four hours prior to infection with FV3,
FHM cells were treated with EP alone (A) or EP containing anti-vPol-IIα (B) or EP plus anti-18K MO (C and D). At 9 h p.i., the cells were fixed and processed for
electron microscopy as described in Methods. The legend is as indicated in Fig. 3. Panel D shows an enlargement of the paracrystalline array shown in panel C.
316 R. Sample et al. / Virology 358 (2007) 311–320translation (Ekker and Larson, 2001). Furthermore, while
siRNAs inhibit translation by triggering the degradation of the
targeted message (Hannon, 2002; Meister and Tuschl, 2004),
asMOs bind mRNA and inhibit translation by impeding
progression of the 40S ribosomal complex (Ekker and Larson,
2001). Although properly designed asMOs block translation of
targeted messages, one disadvantage is that assessment of their
effectiveness requires detecting a decrease in the synthesis of
the targeted protein either by SDS-PAGE, immune precipita-
tion, or Western blotting. Thus, if the targeted protein cannot be
identified by one of the three aforementioned techniques, and if
a marked alteration in viral macromolecular synthesis or yield
cannot be observed, it would not be possible to determine if the
asMO failed to inhibit synthesis of the targeted protein or if the
protein in question is non-essential for virus replication. As
shown above, we were able to specifically inhibit the translation
of three viral messages and infer their function by biochemical
and ultrastructural changes in treated, infected cells.
Our results following targeting of the MCP of FV3 are
similar, but not identical, to those of Xie et al. (2005) who
showed, using short hairpin RNAs (shRNAs) and siRNAs
targeted to theMCP of tiger frog virus (TFV), that degradation ofmRNAs encoding the MCP of TFV was accompanied by corre-
sponding declines in cytopathic effect and viral yields.While our
results using an anti-MCP MO confirm the drop in virus titer
seen by Xie et al., we observed that treatment with anti-MCP
MOs resulted in the generation of atypical elements (AEs) within
viral assembly sites. It is not clear if these structures represent
assembly intermediates that accumulate in the absence of wild-
type levels of MCP synthesis or if they are aberrant structures
that are dead end products of virion assembly. Low levels of
similar AEs are sometimes seen in cells productively infected
with ranaviruses (Huang et al., 2006; AD Hyatt, personal
communication). It is not clear why AEs were seen following
anti-MCP MO treatment but were not detected following
exposure to an siRNA or shRNA targeted against the MCP. It
is unlikely that the difference is due to the fact that Xie et al.
(2005) studied TFVandwe used FV3 since these are very similar
viruses that may represent strains of the same viral species
(Chinchar et al., 2005). Despite these differences, these proof-of-
concept experiments demonstrate the utility of using antisense
technologies to elucidate the function of individual viral pro-
teins. However, one limitation common to both antisense
methodologies is that they are only effective against proteins
Fig. 6. Effect of anti-vPol-IIα MO on viral gene expression. (A) SDS-polyacrylamide gel electrophoresis. FHM cells were treated overnight with the indicated
combinations of EP and MOs and mock-infected (lane 1) or infected with FV3 (lanes 2–7). Protein synthesis was monitored from 7 to 9 h p.i. by labeling with
[35S]methionine and separating the proteins by electrophoresis on 15% SDS-polyacrylamide gels. The positions of the MCP (a late protein) and 18K (an early)
protein are indicated, as are the positions of two other early proteins (designated E1 and E2), and four late proteins identified by asterisks. Molecular weight
markers are shown to the left of the figure. (B–D) Phosphorimager analysis. The effects of treatment with the indicated antisense morpholino oligonucleotides on
MCP synthesis (B), 18K synthesis (C), and vPol-IIα synthesis (D) are shown. The results of three independent experiments are shown.
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(e.g., an immune evasion protein) is required only for growth in
vivo, or if a viral protein is only needed for replication in some
cell lines (e.g., a host range, or efficiency function), then asMOs
and siRNAs may not reduce viral yields in vitro. Despite this
drawback, asMOs and siRNAs will likely provide complimen-
tary methodologies to inhibit the synthesis of specific viral genes
in vitro and thus infer their function.
The results reported herein demonstrate that asMOs targeted
to specific viral mRNAs inhibit translation of those messagesand result in various downstream effects ranging from no
apparent effect, in the case of the anti-18K asMO, to the inhib-
ition of late viral gene expression and virion assembly, in the
case of the anti-vPol-IIα and anti-MCP asMOs, respectively.
Specifically, results using an asMO targeted to the largest
subunit of the viral homolog of Pol II provide the first supportive
evidence that a virus-encoded or virus-modified polymerase is
responsible for late ranavirus gene expression. However, it is not
known if the polymerase responsible for transcribing late viral
messages is a completely virus-encoded enzyme or a chimera of
318 R. Sample et al. / Virology 358 (2007) 311–320host and viral subunits. Moreover, it remains to be determined
(1) if late in infection the transcription of early viral genes is also
catalyzed by the novel polymerase, (2) in which cellular
compartment (nucleus, cytoplasm, or viral assembly sites) the
novel polymerase is found, and (3) the composition of the viral
polymerase. To answer these questions, we are currently at-
tempting to develop an antibody against vPol-IIα so that we
might determine its cellular location andmolecular composition.
The observation that viral assembly sites form in cells pretreated
with anti-vPol-IIα (Fig. 5B) indicates that assembly site
formation does not depend on late gene expression and likely
requires one or more early gene products in addition to viral
DNA. The large size of the assembly sites in treated cells is
surprising given that virion assembly is not taking place. The
electron dense central core seen in Fig. 5B may represent viral
DNA, but it remains to be determined if viral DNA synthesis
continues in treated cells in the absence of virion assembly.
Clearly, enlargement of assembly sites does not depend upon
ongoing virion assembly and may depend on other factors such
as continued viral DNA synthesis or the presence of one or more
early viral proteins. Furthermore, the absence of the AEs within
cells treated with anti-vPol-IIα suggests that their formation is
not due solely to the absence of the MCP since MCP synthesis is
inhibited to comparable levels by both anti-MCP MO and anti-
vPol-IIαMO. Thus, it appears that at least one other late protein
(whose synthesis is inhibited by anti-vPol-IIα) is required for
formation of AEs.
While results with asMOs targeted to the MCP and vPol-IIα
confirmed previous models of ranavirus replication, the results
obtained with an asMO targeted to the 18K immediate-early
protein were unexpected. Earlier work showed that 18K was a
relatively abundant protein that was expressed early in ranavirus
infection, and under conditions where ranavirus DNA and late
protein synthesis was inhibited (Willis et al., 1984, 1985). While
the function of 18K was unknown, its abundance and temporal
class suggested that it was likely an important regulatory protein.
For example, the four alpha (i.e., immediate-early) proteins of
herpes simplex virus type 1 are regulatory proteins that are
required for the synthesis of beta (delayed early) and gamma
(late) genes (Roizman and Sears, 1996). If 18K were to function
in an analogousmanner, one would have expected that inhibition
of its synthesis should have resulted in numerous downstream
effects, including the inhibition of late gene expression. Instead,
we observed that, with the exception of the 18K protein itself,
viral protein synthesis was not adversely affected by pretreat-
ment with the anti-18K MO. Thus, at least in FHM cells, this
protein appears to be non-essential for replication. BLAST
analysis of the FV3 18K protein indicates that it is conserved
among members of the genus Ranavirus, but is not found among
other genera (Lymphocystivirus, Megalocytivirus, or Iridovirus)
within the family. Among ranaviruses, 18K sequence identity/
similarity ranges from 46 to 100%. PsiBLASTanalysis (Altschul
et al., 1997) detected limited sequence identity/similarity to an
intercapsomeric triplex protein of carp pox herpesvirus and the
adenovirus hexon protein, suggesting that 18K may be a virion
protein. Attempts to determine if the domain structure of 18K
was present in other proteins were unsuccessful, that is, therewere no “hits” using the Conserved Domain Architecture
Retrieval Tool (CDART) or Conserved Domain Searches within
NCBI. Since there are several virion proteins within the size
range of 18K, confirmation that 18K is a bona fide virion protein
must await the development of specific antisera. Collectively,
these data indicate that 18K is a protein unique to the genus
Ranavirus and further suggests that it might be a virion-
associated protein that is only required in some cell lines, or a
viral protein that is only required for growth in vivo.
Comparison of virion morphogenesis, viral protein synthesis,
and viral yields showed that EP, and EP plus a control MO, did
not prevent the formation of viral assembly sites (Fig. 5A and
data not shown), but did trigger a modest (∼20–30%) drop in
protein synthesis and a more marked reduction (∼65%) in virus
yields (Fig. 2). We do not know the basis for this differential
affect on protein synthesis and viral yields, but speculate that it
may involve interaction of the transfection reagent with the cell
membrane. It should be noted that the inhibitory effect triggered
by the three specific asMOs was markedly greater than the non-
specific effect induced by EP or EP plus the control MO.
The methodology outlined above, in conjunction with siRNA
approaches currently under development for FV3, should allow
us to assess the roles of iridovirus genes of unknown function in
vitro. Because gene “knock-out” experiments are labor-intensive
and the technology (i.e., homologous recombination) required to
generate viral knock-outs has not yet been successfully applied
to iridoviruses, alternate means of assessing gene function are
needed. asMOs could fill this gap and provide a straightforward
way to screen genes of interest and determine their roles in virus
replication. Since iridoviruses straddle the middle ground
between the cytoplasmic poxviruses and nuclear viruses such
as herpesviruses (Iyer et al., 2001; Allen et al., 2005), elucidating
the function of gene products that mediate viral biogenesis
should not only advance understanding of ranavirus biology, but
also further our understanding of viral evolution (Stasiak et al.,
2003).
Methods
Cells and virus
FV3 was propagated in fathead minnow cells (FHM) grown
in Dulbecco's modified Eagle's medium (DMEM) containing
4% fetal calf serum (D4) at 26 °C in a humidified incubator in
95% air and 5% CO2. Viral titers were determined by TCID50
assay on FHM monolayers.
Antisense morpholinos
asMOs and delivery agents were purchased from GeneTools
(Philomath, OR) and were used according to the manufacturer's
protocol with slight modification. Two different types of
morpholino oligonucleotides and delivery agents were utilized.
In our initial experiments, special delivery (SD) asMOs were
used along with the delivery agent ethoxylated polyethyleni-
mine (EPEI, Morcos, 2001). SD asMOs consist of a pre-paired
duplex of an asMO and a partially complementary DNA
Table 1
Morpholino oligonucleotides
Oligonucleotide Sequence (5′→3′) Position a
Anti-18Kb GCA CAG GTA GGC TTG GAT CAT GCG C +2→+27
Anti-Pol-IIα b AGA TTT AGATGC AAA CAT TTC CAT G −1→+24
Anti-MCPb TGA ACC AGT TAC AGA AGA CAT TTC C −4→+21
CTRL MOc CCT CTT ACC TCA GTT ACA ATT TAT A Not
applicable
a The position of the morpholino is given relative to the translational start
codon with the A of the AUG start codon designated as +1. The sequence
complementary to the start codon is underlined.
b These morpholino oligonucleotides are antisense to viral mRNA and will
inhibit translation by binding the message.
c This is a control MO that does not target any known sequence and thus
serves as a negative control.
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into cultured cells. Although treatment with SD asMOs
successfully knocked down synthesis of the MCP and the
vPol-IIα (data not shown), standard asMOs and the Endo-Porter
(EP) delivery agent were used in the later experiments described
below. The change in protocol took place because EP is less
cytotoxic to cells than EPEI and does not require removal from
treated cells. Sequences of the asMOs used in these studies are
shown in Table 1.
FV3 protein synthesis and virus yields
FHM cells were grown as lightly confluent monolayers
(∼1.6×106 cells/plate) in 35 mm tissue culture dishes. On the
day of assay, the media was removed from each well by
aspiration and replaced with 1 ml of D4. Subsequently, 8 μl of
Endo-Porter and 20 μl of the indicated asMO (final
concentration 10 μM) were added, and the cultures incubated
at 26 °C overnight. The following day (∼24 h after treatment
with asMOs), the cultures were infected with FV3 at a MOI of
∼20 PFU/cell. Replicate cultures were radiolabeled from 7 to
9 h post-infection (p.i.) in methionine-free Eagle's minimum
essential medium with Earle's salts containing 20 μCi/ml [35S]
methionine (Redivue Pro-mix, GE Healthcare). At 9 h p.i., the
radiolabeling medium was removed, and cell lysates were
prepared by disrupting the cells in 300 μl Direct Sample Buffer
(125 mM Tris–HCl, pH 6.8, 10% glycerol, 2% SDS, 0.02% 2-
mercaptoethanol, 0.01% bromophenol blue). Radiolabeled
proteins were separated by electrophoresis on 12 or 15%
SDS-polyacrylamide gels (Laemmili, 1970) and visualized by
autoradiography using Kodak XAR film. The level of target
protein inhibition was determined using a Molecular Dynamics
Fast Scan Series 400 Phosphorimager and Image Quant
software version 5.2 (GE Healthcare). To control for differ-
ences in loading, the final values were normalized based on the
levels of two non-targeted viral proteins. Normalization could
not be performed on cells treated with the anti-vPol-IIα MO
because, as stated below, late protein synthesis was globally
inhibited, and early protein synthesis was slightly enhanced.
To determine virus yields, replicate cultures were infected at an
MOI of ∼5 PFU/cell. After allowing 1 h for adsorption, non-attached virus was removed by washing and the cultures
incubated at 26 °C in D4. The infection was stopped at 24 h p.i.,
and the samples were frozen and thawed three times to release
cell-associated virions, clarified by centrifugation, and the virus
titers determined by TCID50 assay. TCID50 assays were
performed in 96-well plates using confluent FHM monolayers.
Virus was serially diluted 10-fold and after∼7–10 days TCID50
titers were determined using the Karber method (Blake and
O'Connell, 1993).
Transmission electron microscopy
Replicate cultures (2, 60 mm dishes/sample) were treated
with asMOs as previously described and infected at an MOI of
∼20 PFU/cell. At 9 h p.i., the media was removed, and cells
were rinsed gently with 0.1 M sodium phosphate, pH 7.4. The
cells were scraped into fresh buffer, pelleted, fixed in 2%
glutaraldehyde in 0.1 M sodium phosphate buffer, and stored at
4 °C until processed for electron microscopy. At that time, the
samples were post-fixed in 1% osmium tetroxide and stained
with 2% uranyl acetate in de-ionized water. The samples were
dehydrated in a stepwise fashion in ethanol, the ethanol was
removed by treatment with 100% propylene oxide, and the
samples embedded in 100% Epon. Thin sections (0.1 μm) were
floated onto 200 mesh copper hex grids (Electron Microscopy
Science, Fort Washington, PA), counter-stained with lead
citrate, and examined using a Leo 906 (Zeiss) transmission
electron microscope.
Statistical analysis
Viral yields achieved in three separate experiments were
analyzed using a randomized block design ANOVA to assess
differences in titers among treatment categories. To determine
statistical significance at the α=0.05 level, pairwise treatment
comparisons were made using REGWQ, a statistical method
shown to outperform other multiple range tests (Ramsey,
1978). For illustrative purposes, simultaneous 95% confidence
intervals were displayed using Fisher's least-significant-
difference test (LSD) since multiple range tests, such as
REGWQ, do not estimate confidence intervals. It should be
noted the results from REGWQ and LSD analyses are in
agreement.
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